Get up to 90% off - Urjas Oil X
Cavirip is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Tuberculosis.
Medical history of the patient along with age and gender determines the dosage of Cavirip. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The most common side effects of Cavirip are Rash, Erythema, Discoloration of Urine. Apart from the aforementioned side effects, Cavirip can also lead to other problems, which have been listed below. Usually, these side effects of Cavirip go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Cavirip's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Cavirip related warnings talks about Cavirip's effects on the liver, heart and kidney.
The section on Cavirip contraindications lists all such conditions.
Drug reaction of Cavirip with other medicines has been reported. See below for a complete list.
You should also be aware that Cavirip is not safe while driving, and is not addiction.
Cavirip is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Cavirip is used -
Moderate
Common
Is the use of Cavirip safe for pregnant women?
Cavirip may have some side effects during pregnancy. Pregnant women should discontinue the use of Cavirip, and talk to their doctor, if they notice any discomfort.
Is the use of Cavirip safe during breastfeeding?
Cavirip may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Cavirip, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Cavirip.
What is the effect of Cavirip on the Kidneys?
Cavirip can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Cavirip on the Liver?
You may experience side effects on your liver after taking Cavirip. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cavirip on the Heart?
Cavirip can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Cavirip should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Cavirip unless your doctor advises you to do so -
Is this Cavirip habit forming or addictive?
Cavirip does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Cavirip, you should not drive or work on any heavy machine, as Cavirip can make you drowsy.
Is it safe?
Yes, but consume Cavirip only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Cavirip for mental disorders.
Interaction between Food and Cavirip
Taking Cavirip with food is safe.
Interaction between Alcohol and Cavirip
Taking Cavirip with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 768-769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1066-1067
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
Product Description [Internet]: RIFATER® (rifampin, isoniazid and pyrazinamide USP). USFDA
Product Description [Internet]: RIFADIN®. USFDA
Product Description [Internet]: ISONIAZID. Alliance Pharmaceuticals Limited